NCT02349802 - Autoinjector Device Assessment Study | Biotech Hunter

Enrollment

3,052

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions

Healthy Subjects

Interventions

DRUG

Auto-injector with exenatide suspension

A flexible study design to accommodate multiple cohorts.

DRUG

Syringe with exenatide suspension

A flexible study design to accommodate multiple cohorts.

Trial Locations (2)

Research Site, Tempe

Research Site, Lincoln